FdaApplication

NDA 021476

Back to search

Identifiers

Properties

PropertyValue
applicant_nameWAYLIS THERAPEUTICS LLC
application_typeNDA
approval_date2004-12-15

Products (3)

ProductActive ingredientStrengthDosage form
LUNESTAESZOPICLONE1MGTABLET;ORAL
LUNESTAESZOPICLONE2MGTABLET;ORAL
LUNESTAESZOPICLONE3MGTABLET;ORAL

3 products